Table 6 Evaluation and analysis of miRNA in the validation set (\(\bar x \pm \;{\rm{s}}\))
Index | Specificity | Sensitivity |
|---|---|---|
All subjects | 84.37% | 77.29% |
Histological types | ||
glandular cancer | 84.37% | 75.33% |
Squamous cell carcinoma | 84.37% | 76.49% |
Stages | ||
I | 84.37% | 75.00% |
II | 84.37% | 79.21% |
III | 84.37% | 73.48% |